Autonomix CEO Hauser touts growing conference recognition for nerve-sensing platform in CEO Corner interview

Autonomix Medical, Inc.

Autonomix Medical, Inc.

AMIX

0.00
  • Autonomix released a new CEO Corner interview featuring President and CEO Brad Hauser on global scientific and clinical traction for its nerve-sensing platform.
  • Hauser cited 13 abstract acceptances since last fall, including nine podium presentations, as peer-reviewed validation of the technology’s novelty and potential impact.
  • Management framed the visibility as support for physician adoption, upcoming clinical trials, partnership talks, reimbursement planning, and a planned U.S. clinical study.
  • The interview highlighted pancreatic cancer pain as a key target use case for the company’s real-time nerve sensing and transvascular denervation approach.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606100905PRIMZONEFULLFEED9734498) on June 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.